Youn Ju Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Youn Ju Lee has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
So-Young Choi
Department of Pharmacology/Toxicology, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea
2 shared publicationsEunkyung Lee
Research and Development Division, Korea Promotion Institute for Traditional Medicine Industry, Gyeongsan 38540, Korea
1 shared publication- Eunkyung Lee
Research and Development Division, National Development Institute of Korean Medicine, Gyeongsan, 712-260, Republic of Korea.
1 shared publication - Hwadong Lee
Research and Development Division, Korea Promotion Institute for Traditional Medicine Industry, Gyeongsan 712-260, Republic of Korea
1 shared publication - Hyo Hyun Park
Research and Development Division, Korea Promotion Institute for Traditional Medicine Industry, Gyeongsan 712-260, Korea
1 shared publication Jae H. Yang
Department of Pharmacology/Toxicology, School of Medicine, Catholic University of Daegu, Daegu, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 20 (4) , 399-406
Preventive effects of imperatorin on perfluorohexanesulfonate-induced neuronal apoptosis via inhibition of intracellular calcium-mediated ERK pathway
Lee E, et al. Korean J Physiol Pharmacol. 2016 Jul;20(4):399-406. http://dx.doi.org/10.4196/kjpp.2016.20.4.399
- 1 January 2016
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 20 (4) , 399-406
Open AccessPreventive effects of imperatorin on perfluorohexanesulfonate-induced neuronal apoptosis via inhibition of intracellular calcium-mediated ERK pathway
Lee E, et al. Korean J Physiol Pharmacol. 2016 Jul;20(4):399-406. http://dx.doi.org/10.4196/kjpp.2016.20.4.399
- 1 September 2014
- Published by Elsevier in Science of The Total Environment
- Vol. 491-492, 227-234
NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells
- 1 September 2014
- Published by Elsevier in Science of The Total Environment
- Vol. 491-492, 227-234
NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells
- Open Access
- 12 February 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 54
Anti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis
Biyeom-Tang, a medicine prescribed by oriental clinics, has been used for the treatment of the allergic rhinitis (AR). In the present study, an ethanol extract of Biyeom-Tang (EBT) was investigated for anti-allergic properties on bone-marrow derived mast cells (BMMC) and in vivo models. The anti-allergic properties of EBT were evaluated by measuring β-Hex release and the production of prostaglandin D2 (PGD2) and leukotriene C4 (LTC4) on BMMC in vitro and PCA and OVA-induced AR models in vivo. EBT strongly inhibited a degranulation reaction in a dose dependent manner with an IC50 value of 35.6 μg/ml. In addition, the generation of PGD2 and LTC4 was inhibited in BMMC in a concentration-dependent manner with IC50 values of 7.0 μg/ml and 10.9 μg/ml, respectively. When administrated orally, EBT ameliorated the mast cell-mediated PCA reaction. In the OVA-induced AR model, the increased levels of IgE were reduced by EBT. The levels of cytokines, such as IL-4, IL-5, IL-10, and IL-13 decreased in the splenocytes of EBT-treated mice. The histological analysis shows that the infiltration of inflammatory cells increased by OVA-sensitization was also reduced. Taken together, these results suggested that EBT has anti-allergic and anti-inflammatory effects in vitro and in vivo models.
- 12 February 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 54
Open AccessAnti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis
Biyeom-Tang, a medicine prescribed by oriental clinics, has been used for the treatment of the allergic rhinitis (AR). In the present study, an ethanol extract of Biyeom-Tang (EBT) was investigated for anti-allergic properties on bone-marrow derived mast cells (BMMC) and in vivo models. The anti-allergic properties of EBT were evaluated by measuring β-Hex release and the production of prostaglandin D2 (PGD2) and leukotriene C4 (LTC4) on BMMC in vitro and PCA and OVA-induced AR models in vivo. EBT strongly inhibited a degranulation reaction in a dose dependent manner with an IC50 value of 35.6 μg/ml. In addition, the generation of PGD2 and LTC4 was inhibited in BMMC in a concentration-dependent manner with IC50 values of 7.0 μg/ml and 10.9 μg/ml, respectively. When administrated orally, EBT ameliorated the mast cell-mediated PCA reaction. In the OVA-induced AR model, the increased levels of IgE were reduced by EBT. The levels of cytokines, such as IL-4, IL-5, IL-10, and IL-13 decreased in the splenocytes of EBT-treated mice. The histological analysis shows that the infiltration of inflammatory cells increased by OVA-sensitization was also reduced. Taken together, these results suggested that EBT has anti-allergic and anti-inflammatory effects in vitro and in vivo models.